يعرض 1,941 - 1,960 نتائج من 14,878 نتيجة بحث عن '(( significantly increased decrease ) OR ( significantly ((we decrease) OR (nn decrease)) ))', وقت الاستعلام: 0.50s تنقيح النتائج
  1. 1941
  2. 1942

    Increased CN inhibition leads to reduced STO frequency and to more CSpk frequency. حسب Elías M. Fernández Santoro (22470299)

    منشور في 2025
    "…(E) Increase in CN-to-IO inhibitory synapses, and thus inhibition strength, led to a decrease in IO STO frequency and a concurrent increase in CSpk frequency.…"
  3. 1943

    MXene/Bi<sub>2</sub>O<sub>3</sub> Nanocomposites as Supercapacitors for Portable Electronic Devices حسب Nanasaheb M. Shinde (8560572)

    منشور في 2025
    "…2D MXene nanosheets often encounter challenges such as aggregation and restacking, which can significantly decrease their performance in supercapacitor applications. …"
  4. 1944
  5. 1945
  6. 1946
  7. 1947
  8. 1948
  9. 1949
  10. 1950

    The results of linear mixed model. حسب Soheila Qanbari (20455173)

    منشور في 2024
    الموضوعات:
  11. 1951
  12. 1952
  13. 1953
  14. 1954
  15. 1955
  16. 1956
  17. 1957
  18. 1958

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  19. 1959

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  20. 1960

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"